Breast lumps other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Removing from Primary care)
 
(25 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Breast lumps}}
{{Breast lumps}}


{{CMG}}
{{CMG}}; {{AE}} {{S.M}}
==Overview==
The only certain method to approve the presence of breast [[malignancy]] is [[breast lump]] [[biopsy]].The three types of biopsies are core-needle biopsy, open surgical biopsy, and fine needle biopsy. Core-needle biopsy has different types such as ultrasound guided-core needle biopsy, stereotactic-guided core-needle biopsy, MRI-guided core-needle biopsy, and freehand core-needle biopsy. Core-needle biopsy has high [[sensitivity]] and [[specificity]]. [[Triple test]] score is used by surgeons for assessment of palpable [[breast lumps]]. Classic type of triple test includes clinical breast examination, [[FNA]], and [[mammography]] and modified version includes clinical breast examination, core-needle biopsy and [[ultrasound]].
 
== Other Diagnostic Studies==
== Other Diagnostic Studies==
Biopsy
===Biopsy===
The only certain method to approve the presence of breast malignancy is breast lump biopsy <ref> John M. Eisenberg Center for Clinical Decisions and Communications Science. Having a Breast Biopsy: A Review of the Research for Women and Their Families. 2016 May 26. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368364/ </ref>


There are three types of biopsy  
The only certain method to approve the presence of breast malignancy is [[breast lump]] [[biopsy|biopsy.]]<ref name=":0">John M. Eisenberg Center for Clinical Decisions and Communications Science. Having a Breast Biopsy: A Review of the Research for Women and Their Families. 2016 May 26. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368364/ </ref>
*Core needle biopsy
 
There are three types of biopsy:
*Core-needle biopsy
*Open surgical biopsy
*Open surgical biopsy
*Fine needle biopsy <ref> Casaubon JT, Regan JP. Breast Masses, Fine Needle Aspiration. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470268/</ref>
*Fine needle biopsy<ref name=":1">Casaubon JT, Regan JP. Breast Masses, Fine Needle Aspiration. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470268/</ref>
 
'''Core-needle biopsy:'''<ref name=":0" />
*[[Ultrasound]] guided-core needle biopsy:<ref name="pmid11698631">{{cite journal| author=Yeow KM, Lo YF, Wang CS, Chang HK, Tsai CS, Hsueh C| title=Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses. | journal=J Vasc Interv Radiol | year= 2001 | volume= 12 | issue= 11 | pages= 1313-7 | pmid=11698631 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11698631  }} </ref>
**The needle is guided by use of [[ultrasound]] and patient lies on back or side
** Highly [[sensitivity]] and [[specificity]]
**Choice method for breast tissue sampling
*Stereotactic-guided core-needle biopsy
**The needle is guided by use of [[x-ray]] and computer and patient lie on [[stomach]].
**Choice method for mammograohically suspicious [[breast lumps]] which are occult in [[ultrasound|ultrasound.]]<ref name="pmid20074953">{{cite journal| author=Ward ST, Shepherd JA, Khalil H| title=Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinic. | journal=Breast | year= 2010 | volume= 19 | issue= 2 | pages= 105-8 | pmid=20074953 | doi=10.1016/j.breast.2009.12.003 | pmc= | url=htps://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20074953  }} </ref>
*MRI-guided core-needle biopsy
**The needle is guided by [[Magnetic resonance imaging]].
*Freehand core-needle biopsy
**Usually used for [[breast lumps]] which can be felt by hand on breast tissue.
Core-needle biopsy has lower risk of [[complications]] such as [[bleeding]], [[bruising]] and [[infection]]
 
'''Open surgical biopsy:'''<ref name=":0" />
*Perform under [[general anesthesia]]
*If core-needle biopsy is unavailable due to location of breast lump, open surgical biopsy is required
*In patients with high risk of [[cancer]] is recommended
*1-2 inch cut on breast tissue for breast lump removal
*Higher risk of [[complications]] ([[bruising]], [[bleeding]], [[pain]] and [[infection]])
Fine needle biopsy ([[FNA]]):<ref name=":1" />
*Performed by small needle (21-25 gauge)
*Regarding to small amount of breast tissue, [[FNA]] is considered as controversial method for breast lump diagnosis
*Performed for large and symptomatic breast [[cysts]] or imaginary abnormalities
*Complications of [[FNA]] include [[bruising]], [[bleeding]], [[pain]], [[infection]] and [[pneumothorax]]; if needle goes deep inside the chest)
*Due to inadequate tissue or nondiagnostic results, [[FNA]] has lower rate of diagnosis rather than core-needle biopsy
*[[FNA]] advantages:
**[[Cost-effectiveness]]
**Less [[invasive]] method
**Suitable for patient under [[anticoagulant therapy]]
**Appropriate to sample axillary tissue
*[[FNA]] follow-up:
**Non-bloody fluid/resolved [[cyst]]
*** [[Ultrasound]] follow-up to reassure the [[cyst]] has been resolved
***No more follow-up
**Bloody fluid/ persistent [[cyst]]
***Refer to a surgeon for open surgical [[biopsy]]
 
[[Triple test]] score is used by surgeons for assessment of palpable [[breast lumps]]:<ref>Morris KT, Pommier RF, Morris A, et al. Usefulness of the Triple Test Score for Palpable Breast Masses. Arch Surg. 2001;136(9):1008–1013. doi:10.1001/archsurg.136.9.1008</ref><ref name="pmid23104707">{{cite journal| author=Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y et al.| title=A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. | journal=Ann Surg Oncol | year= 2013 | volume= 20 | issue= 3 | pages= 850-5 | pmid=23104707 | doi=10.1245/s10434-012-2710-y | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23104707  }} </ref>
 
*Classic [[triple test]]:
**Clinical breast examination, [[FNA]] and [[mammography]]
*Modified version of [[triple test]]
**Clinical breast examination, Core-needle biopsy and [[ultrasound]]
*[[Palpation]], [[mammography]] and [[biopsy]] are required for women aged > 35 years<ref>Santen RJ. Benign Breast Disease in Women. [Updated 2018 May 25]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278994/</ref>
**If [[mammography]] is negative, [[biopsy]] is needed to rule out [[malignancy]] especially [[Lobular carcinoma in situ|lobular carcinoma]]
*[[Palpation]], [[ultrasound]] and [[biopsy]] are suggested for women <35 years
**Surgeons may omit [[biopsy]] for [[fibroadenoma]] features on [[ultrasound]] and prefer 6 month follow-up for 2 years
**Some surgeons recommend core-needle biopsy or [[FNA]] for all [[fibroadenomas]]
***Particularly in carriers of [[BRCA]] [[mutation]]
*** Reduce the need for serial [[ultrasound]]


==References==
==References==
Line 18: Line 74:
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:primary care]]
[[Category:Up-To-Date]]
[[Category:Disease]]
[[Category:Musculoskeletal Disease]]
[[Category:Physical examination]]
[[Category:Needs overview]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Surgery]]
[[Category:Surgery]]

Latest revision as of 20:42, 29 July 2020

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps other diagnostic studies

on Breast lumps other diagnostic studies

Breast lumps other diagnostic studies in the news

Blogs on Breast lumps other diagnostic studies

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

The only certain method to approve the presence of breast malignancy is breast lump biopsy.The three types of biopsies are core-needle biopsy, open surgical biopsy, and fine needle biopsy. Core-needle biopsy has different types such as ultrasound guided-core needle biopsy, stereotactic-guided core-needle biopsy, MRI-guided core-needle biopsy, and freehand core-needle biopsy. Core-needle biopsy has high sensitivity and specificity. Triple test score is used by surgeons for assessment of palpable breast lumps. Classic type of triple test includes clinical breast examination, FNA, and mammography and modified version includes clinical breast examination, core-needle biopsy and ultrasound.

Other Diagnostic Studies

Biopsy

The only certain method to approve the presence of breast malignancy is breast lump biopsy.[1]

There are three types of biopsy:

  • Core-needle biopsy
  • Open surgical biopsy
  • Fine needle biopsy[2]

Core-needle biopsy:[1]

Core-needle biopsy has lower risk of complications such as bleeding, bruising and infection

Open surgical biopsy:[1]

Fine needle biopsy (FNA):[2]

  • Performed by small needle (21-25 gauge)
  • Regarding to small amount of breast tissue, FNA is considered as controversial method for breast lump diagnosis
  • Performed for large and symptomatic breast cysts or imaginary abnormalities
  • Complications of FNA include bruising, bleeding, pain, infection and pneumothorax; if needle goes deep inside the chest)
  • Due to inadequate tissue or nondiagnostic results, FNA has lower rate of diagnosis rather than core-needle biopsy
  • FNA advantages:
  • FNA follow-up:
    • Non-bloody fluid/resolved cyst
      • Ultrasound follow-up to reassure the cyst has been resolved
      • No more follow-up
    • Bloody fluid/ persistent cyst
      • Refer to a surgeon for open surgical biopsy

Triple test score is used by surgeons for assessment of palpable breast lumps:[5][6]

References

  1. ↑ 1.0 1.1 1.2 John M. Eisenberg Center for Clinical Decisions and Communications Science. Having a Breast Biopsy: A Review of the Research for Women and Their Families. 2016 May 26. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368364/
  2. ↑ 2.0 2.1 Casaubon JT, Regan JP. Breast Masses, Fine Needle Aspiration. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470268/
  3. ↑ Yeow KM, Lo YF, Wang CS, Chang HK, Tsai CS, Hsueh C (2001). "Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses". J Vasc Interv Radiol. 12 (11): 1313–7. PMID 11698631.
  4. ↑ Ward ST, Shepherd JA, Khalil H (2010). [htps://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20074953 "Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinic"]. Breast. 19 (2): 105–8. doi:10.1016/j.breast.2009.12.003. PMID 20074953.
  5. ↑ Morris KT, Pommier RF, Morris A, et al. Usefulness of the Triple Test Score for Palpable Breast Masses. Arch Surg. 2001;136(9):1008–1013. doi:10.1001/archsurg.136.9.1008
  6. ↑ Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y; et al. (2013). "A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy". Ann Surg Oncol. 20 (3): 850–5. doi:10.1245/s10434-012-2710-y. PMID 23104707.
  7. ↑ Santen RJ. Benign Breast Disease in Women. [Updated 2018 May 25]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278994/


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Breast_lumps_other_diagnostic_studies&oldid=1635429"